novoprolabs retatrutide Eli Lilly's Retatrutide: Gym Goers Are Taking Knock Offs Before Launch How to Get Retatrutide |

The retatrutide dosage calculator can help determine appropriate starting points based on individual parameters

Personalised approach to weight management As with any medical intervention, the response to weight loss medications can vary among individuals

See our supplements evidence guide

Written by: Anela Martinovi, PhD, together with Gali Artzi, PhD, Eva Everloo, Nurit Ben, & Taire Brown The Rise of GLP-1 Just a few short years ago, the term GLP-1 or Ozempic would have meant little to the average person

As with any pharmaceutical intervention, there are specific criteria and considerations for its use: Suitable candidates for cagrilintide treatment typically include: Adults with a Body Mass Index (BMI) of 30 or greater (classified as obese) Adults with a BMI of 27 or greater (overweight) with at least one weight-related comorbidity, such as hypertension, type 2 diabetes, or dyslipidemia Individuals who have not achieved sufficient weight loss through diet and exercise alone Patients without contraindications to amylin analogs or GLP-1 receptor agonists (when used in combination) It's crucial to note that cagrilintide is not recommended for certain groups, including: Pregnant or breastfeeding women Individuals with a personal or family history of medullary thyroid carcinoma Patients with Multiple Endocrine Neoplasia syndrome type 2 Those with a history of pancreatitis or severe gastrointestinal disorders Before initiating treatment with cagrilintide, a comprehensive medical evaluation is necessary